Cypress Prosorba Rheumatoid Arthritis PMA Submission Slated For Mid-year
This article was originally published in The Gray Sheet
Executive Summary
Cypress Bioscience is planning a mid-1998 premarket approval application submission for the Prosorba immunoadsorption column in treating severe rheumatoid arthritis, the San Diego-based company says.